Jaguar Health Corp - Wutah dodolan YoY (TTM) JAGX

Logo perusahaan publik Jaguar Health Corp (JAGX)

Jaguar Health, Inc. (JAGX) management is actively seeking new sales markets for plant-based gastrointestinal treatments, which GURU.Markets reflects through year-over-year revenue dynamics over the last 12 months via volatility, where the value of 130.00 characterizes this level. Growth is driven by the scaling of Mytesi and the expansion of insurance coverage, while a stable neutral backdrop and patent protection minimize geopolitical risks.

JAGX Jaguar Health Inc: Wutah dodolan YoY sajrone rolas wulan kepungkur ing interval 11.02.2024 - 18.11.2026

Jaguar Health (JAGX) - rincian metrik lan laporan keuangan

- rega lan prakiraan konsensus rega:
Ringkesan analitik perusahaan:Jaguar Health, Inc.
Produk merek jaguar.health

This indicator measures rolling year revenue dynamics, allowing investors to assess business expansion rates and demand stability without the volatility of quarterly reporting. By analyzing the YoY sales growth over the last four quarters, one can confirm the effectiveness of diversifying raw material supplies from the Amazon, which minimizes logistical risks in the production of Jaguar Health, Inc. (JAGX) prescription drugs.